IP Library Granted Patent US 9,988,609
Granted Patent B2
US 9,988,609 · App. 15/108,320 · Granted Jun 5, 2018

Fructose amino acid oxidase, preparation method and enzyme-containing kit for detecting glycated albumin

Inventors: Bingde Zou (Ningbo, CN); Jihua Zou (Ningbo, CN); Yi Wang (Ningbo, CN); Jianghua Jia (Ningbo, CN)
Assignee: MEDICAL SYSTEM BIOTECHNOLOGY CO., LTD.
C12N9/0032C12Y105/03G01N33/6842G01N2333/765G01N2333/90638G01N2333/90672
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,988,609
App. No.
15/108,320
Granted
Jun 5, 2018
Kind
B2
Abstract

Fructosyl amino acid oxidase is provided, which has an amino acid sequence as shown in SEQID. No. 1 or fructosyl amino acid oxidase having a homology of more than 80% with this amino acid sequence, on a corresponding site of an amino acid selected from following (a) to (f), having one or more amino acid residues conducting a substitution, obtained fructosyl amino acid oxidase having a higher thermostability: (a) 59-site glutamic acid, (b) 98-site glutamic acid, (c) 225-site glycine, (d) 277-site lysine, (e) 285-site glutamic acid, and (f) 355-site aspartic acid. The method for preparing the above oxidase and the test kit containing the enzyme for determining glycated albumin are also provided.

Claims (19)

1. A fructosyl amino acid oxidase comprising the amino acid sequence of SEQ ID No: 1, wherein glutamic acid at position 59 of SEQ ID No: 1 is substituted with an amino acid selected from the group consisting of L, I, V, F, M, W, T, C, N, Y, D, and H, and wherein the fructosyl amino acid exhibits a higher thermostability compared to the fructosyl amino acid oxidase of SEQ ID No: 1.

2. A fructosyl amino acid oxidase comprising the amino acid sequence of SEQ ID No: 1, wherein glutamic acid at position 59 of SEQ ID No: 1 is substituted with phenylalanine (F), wherein the fructosyl amino acid oxidase further comprises an additional substitution to SEQ ID No: 1 selected from the group consisting of substitutions (a) to (k), wherein the fructosyl amino acid exhibits a higher thermostability compared to the fructosyl amino acid oxidase of SEQ ID No: 1, and wherein the substitutions (a) to (k) are as follows:

(a) E98C

(b) G225D

(c) K227N

(d) E285F

(e) E98C and G225F

(f) G225D and K227N

(g) K227N and E285I

(h) E98C, G225F, and K277N

(i) G225D, K277N, and E285F

(j) E98C, G225F, K277N, and E285F

(k) E98C, G225F, K227N, E285F, and D355L.

3. A polynucleotide encoding the fructosyl amino acid oxidase of claim 1 .

4. A test kit for determining glycated albumin, the kit comprising a reagent 1 and reagent 2, wherein reagent 1 comprises 20-200 mM buffer, 10-100 KU/L protease, 10-100 KU/L peroxidase, 5-50 mM 4-amino-antipyrine, and 0.01 to 0.05% preservative, and wherein reagent 2 comprises 20-200 mM buffer, 10-100 KU/L of the fructosyl amino acid oxidase of claim 1 , 1-10 mM chromogen, and 0.01 to 0.05% preservative.

5. The test kit of claim 4 , wherein the buffer is selected from the group consisting of tris-hydrochloride buffer, acetic acid-sodium acetate buffer, phthalic-acid-hydrochloric acid buffer, and glycine-hydrochloric acid buffer.

6. The test kit of claim 4 , wherein the protease is selected from the group consisting of trypsin, basophilic protease, proteinase A, and proteinase K.

7. The test kit of claim 4 , wherein chromogen is selected from the group consisting of N, N-di(4-sulfobutyl)-3-methylaniline disodium salt, N-ethyl-N-(3-sulfopropyl)-3-methylaniline sodium salt, and N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline sodium salt.

8. The test kit of claim 4 , wherein the preservative is 2-methyl-4-isothiazolin-3-one.

Assignments (2)
CHANGE OF NAME Recorded Apr 28, 2018
From: NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO., LTD.
To: MEDICAL SYSTEM BIOTECHNOLOGY CO., LTD.
Reel/Frame 046035/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2016
From: ZOU, BINGDE; ZOU, JIHUA; WANG, YI; JIA, JIANGHUA
To: NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO., LTD.
Reel/Frame 039166/0236 →
Priority Claims (1)
CN 2013 1 0744635 · Dec 27, 2013 · national
Continuity (1)
Related Publication 20160319248A1 · Nov 3, 2016